Relationship Between Duration of Untreated Psychosis and Outcome in First-Episode Schizophrenia: A Critical Review and Meta-Analysis
Tóm tắt
Từ khóa
Tài liệu tham khảo
Lieberman JA, Perkins D, Belger A, Chakos M, Jarskog F, Boteva K, Gilmore J: The early stages of schizophrenia: speculations on pathogenesis, pathophysiology, and therapeutic approaches. Biol Psychiatry 2001; 50:884–897
McGorry PD, Edwards J, Mihalopoulos C, Harrigan SM, Jackson HJ: EPPIC: an evolving system of early detection and optimal management. Schizophr Bull 1996; 22:305–326
Linszen D, Lenior M, de Haan L, Dingemans P, Gersons B: Early intervention, untreated psychosis and the course of early schizophrenia. Br J Psychiatry Suppl 1998; 172:84–89
Malla AK, Norman RM, Manchanda R, McLean TS, Harricharan R, Cortese L, Townsend LA, Scholten DJ: Status of patients with first-episode psychosis after one year of phase-specific community-oriented treatment. Psychiatr Serv 2002; 53:458–463
Johannessen JO, McGlashan TH, Larsen TK, Horneland M, Joa I, Mardal S, Kvebaek R, Friis S, Melle I, Opjordsmoen S, Simonsen E, Ulrik H, Vaglum P: Early detection strategies for untreated first-episode psychosis. Schizophr Res 2001; 51:39–46
Lieberman JA, Sheitman B, Chakos M, Robinson D, Schooler N, Keith S: The development of treatment resistance in patients with schizophrenia: a clinical and pathophysiologic perspective. J Clin Psychopharmacol 1998; 18:20S-24S
McGlashan TH: Duration of untreated psychosis in first-episode schizophrenia: marker or determinant of course? Biol Psychiatry 1999; 46:899–907
Bottlender R, Strauss A, Moller HJ: Impact of duration of symptoms prior to first hospitalization on acute outcome in 998 schizophrenic patients. Schizophr Res 2000; 44:145–150
Bottlender R, Sato T, Jager M, Wegener U, Wittmann J, Strauss A, Moller HJ: The impact of the duration of untreated psychosis prior to first psychiatric admission on the 15-year outcome in schizophrenia. Schizophr Res 2003; 62:37–44
Melle I, Larsen TK, Haahr U, Friis S, Johannessen JO, Opjordsmoen S, Simonsen E, Rund BR, Vaglum P, McGlashan T: Reducing the duration of untreated first-episode psychosis: effects on clinical presentation. Arch Gen Psychiatry 2004; 61:143–150
Wiersma D, Wanderling J, Dragomirecka E, Ganev K, Harrison G, an der Heiden W, Nienhuis FJ, Walsh D: Social disability in schizophrenia: its development and prediction over 15 years in incidence cohorts in six European centres. Psychol Med 2000; 30:1155–1167
Harrigan SM, McGorry PD, Krstev H: Does treatment delay in first-episode psychosis really matter? Psychol Med 2003; 33:97–110
Addington J, van Mastrigt S, Addington D: Duration of untreated psychosis: impact on 2-year outcome. Psychol Med 2004; 34:277–284
Perkins D, Lieberman J, Gu H, Tohen M, McEvoy J, Green A, Zipursky R, Strakowski S, Sharma T, Kahn R, Gur R, Tollefson G: Predictors of antipsychotic treatment response in patients with first-episode schizophrenia, schizoaffective and schizophreniform disorders. Br J Psychiatry 2004; 185:18–24
Ho B-C, Andreasen NC, Flaum M, Nopoulos P, Miller D: Untreated initial psychosis: its relation to quality of life and symptom remission in first-episode schizophrenia. Am J Psychiatry 2000; 157:808–815; correction, 2001; 158:986
Malla AK, Norman RM, Manchanda R, Townsend L: Symptoms, cognition, treatment adherence and functional outcome in first-episode psychosis. Psychol Med 2002; 32:1109–1119
Robinson D, Woerner MG, Alvir JM, Bilder R, Goldman R, Geisler S, Koreen A, Sheitman B, Chakos M, Mayerhoff D, Lieberman JA: Predictors of relapse following response from a first episode of schizophrenia or schizoaffective disorder. Arch Gen Psychiatry 1999; 56:241–247
Wiersma D, Nienhuis FJ, Slooff CJ, Giel R: Natural course of schizophrenic disorders: a 15-year followup of a Dutch incidence cohort. Schizophr Bull 1998; 24:75–85
Szymanski SR, Cannon TD, Gallacher F, Erwin RJ, Gur RE: Course of treatment response in first-episode and chronic schizophrenia. Am J Psychiatry 1996; 153:519–525
Craig TJ, Bromet EJ, Fennig S, Tanenberg-Karant M, Lavelle J, Galambos N: Is there an association between duration of untreated psychosis and 24-month clinical outcome in a first-admission series? Am J Psychiatry 2000; 157:60–66
Verdoux H, Liraud F, Bergey C, Assens F, Abalan F, van Os J: Is the association between duration of untreated psychosis and outcome confounded? a two year follow-up study of first-admitted patients. Schizophr Res 2001; 49:231–241
Crow TJ, MacMillan JF, Johnson AL, Johnstone EC: A randomised controlled trial of prophylactic neuroleptic treatment. Br J Psychiatry 1986; 148:120–127
Drake RJ, Haley CJ, Akhtar S, Lewis SW: Causes and consequences of duration of untreated psychosis in schizophrenia. Br J Psychiatry 2000; 177:511–515
Barnes TR, Hutton SB, Chapman MJ, Mutsatsa S, Puri BK, Joyce EM: West London first-episode study of schizophrenia: clinical correlates of duration of untreated psychosis. Br J Psychiatry 2000; 177:207–211
Robinson DG, Woerner MG, Alvir JMJ, Geisler S, Koreen A, Sheitman B, Chakos M, Mayerhoff D, Bilder R, Goldman R, Lieberman JA: Predictors of treatment response from a first episode of schizophrenia or schizoaffective disorder. Am J Psychiatry 1999; 156:544–549
Madsen AL, Karle A, Rubin P, Cortsen M, Andersen HS, Hemmingsen R: Progressive atrophy of the frontal lobes in first-episode schizophrenia: interaction with clinical course and neuroleptic treatment. Acta Psychiatr Scand 1999; 100:367–374
Hoff AL, Sakuma M, Razi K, Heydebrand G, Csernansky JG, DeLisi LE: Lack of association between duration of untreated illness and severity of cognitive and structural brain deficits at the first episode of schizophrenia. Am J Psychiatry 2000; 157:1824–1828
Larsen TK, Moe LC, Vibe-Hansen L, Johannessen JO: Premorbid functioning versus duration of untreated psychosis in 1 year outcome in first-episode psychosis. Schizophr Res 2000; 45:1–9
Browne S, Clarke M, Gervin M, Waddington JL, Larkin C, O’Callaghan E: Determinants of quality of life at first presentation with schizophrenia. Br J Psychiatry 2000; 176:173–176
Malla AK, Norman RMG, Manchanda R, Ahmed MR, Scholten D, Harricharan R, Cortese L, Takhar J: One year outcome in first episode psychosis: influence of DUP and other predictors. Schizophr Res 2002; 54:231–242
Norman RM, Townsend L, Malla AK: Duration of untreated psychosis and cognitive functioning in first-episode patients. Br J Psychiatry 2001; 179:340–345
Ho B-C, Alicata D, Ward J, Moser DJ, O’Leary DS, Arndt S, Andreasen NC: Untreated initial psychosis: relation to cognitive deficits and brain morphology in first-episode schizophrenia. Am J Psychiatry 2003; 160:142–148
Rund BR, Melle I, Friis S, Larsen TK, Midbøe LJ, Opjordsmoen S, Simonsen E, Vaglum P, McGlashan T: Neurocognitive dysfunction in first-episode psychosis: correlates with symptoms, premorbid adjustment, and duration of untreated psychosis. Am J Psychiatry 2004; 161:466–472
Amminger GP, Edwards J, Brewer WJ, Harrigan S, McGorry PD: Duration of untreated psychosis and cognitive deterioration in first-episode schizophrenia. Schizophr Res 2002; 54:223–230
Townsend LA, Norman RM, Malla AK, Rychlo AD, Ahmed RR: Changes in cognitive functioning following comprehensive treatment for first episode patients with schizophrenia spectrum disorders. Psychiatry Res 2002; 113:69–81
Malla AK, Mittal C, Lee M, Scholten DJ, Assis L, Norman RM: Computed tomography of the brain morphology of patients with first-episode schizophrenic psychosis. J Psychiatry Neurosci 2002; 27:350–358
Fannon D, Chitnis X, Doku V, Tennakoon L, Ó’Ceallaigh S, Soni W, Sumich A, Lowe J, Santamaria M, Sharma T: Features of structural brain abnormality detected in first-episode psychosis. Am J Psychiatry 2000; 157:1829–1834
Verdoux H, Bergey C, Assens F, Abalan F, Gonzales B, Pauillac P, Fournet O, Liraud F, Beaussier JP, Gaussares C, Etchegaray B, Bourgeois M, van Os J: Prediction of duration of psychosis before first admission. Eur Psychiatry 1998; 13:346–352
Lieberman JA, Phillips M, Gu H, Stroup S, Zhang P, Kong L, Ji Z, Koch G, Hamer RM: Atypical and conventional antipsychotic drugs in treatment-naive first-episode schizophrenia: a 52-week randomized trial of clozapine vs chlorpromazine. Neuropsychopharmacology 2003; 28:995–1003
Ring N, Tantam D, Montague L, Newby D, Black D, Morris J: Gender differences in the incidence of definite schizophrenia and atypical psychosis—focus on negative symptoms of schizophrenia. Acta Psychiatr Scand 1991; 84:489–496
Larsen TK, McGlashan TH, Moe LC: First-episode schizophrenia, I: early course parameters. Schizophr Bull 1996; 22:241–256
Rabiner CJ, Wegner JT, Kane JM: Outcome study of first-episode psychosis, I: relapse rates after 1 year. Am J Psychiatry 1986; 143:1155–1158
Black K, Peters L, Rui Q, Milliken H, Whitehorn D, Kopala LC: Duration of untreated psychosis predicts treatment outcome in an early psychosis program. Schizophr Res 2001; 47:215–222
Haas GL, Sweeney JA: Premorbid and onset features of first-episode schizophrenia. Schizophr Bull 1992; 18:373–386
Ucok A, Polat A, Genc A, Cakiotar S, Turan N: Duration of untreated psychosis may predict acute treatment response in first-episode schizophrenia. J Psychiatr Res 2004; 38:163–168
Kalla O, Aaltonen J, Wahlstrom J, Lehtinen V, Garcia Cabeza I, Gonzalez de Chavez M: Duration of untreated psychosis and its correlates in first-episode psychosis in Finland and Spain. Acta Psychiatr Scand 2002; 106:265–275
Kua J, Wong KE, Kua EH, Tsoi WF: A 20-year follow-up study on schizophrenia in Singapore. Acta Psychiatr Scand 2003; 108:118–125
de Haan L, Linszen DH, Lenior ME, de Win ED, Gorsira R: Duration of untreated psychosis and outcome of schizophrenia: delay in intensive psychosocial treatment versus delay in treatment with antipsychotic medication. Schizophr Bull 2003; 29:341–348
Hafner H, Riecher-Rossler A, Hambrecht M, Maurer K, Meissner S, Schmidtke A, Fatkenheuer B, Loffler W, van der Heiden W: IRAOS: an instrument for the assessment of onset and early course of schizophrenia. Schizophr Res 1992; 6:209–223
McGorry PD, Singh BS, Copolov DL, Kaplan I, Dossetor CR, Van Riel RJ: Royal Park Multidiagnostic Instrument for Psychosis, part II: development, reliability, and validity. Schizophr Bull 1990; 16:517–536
Endicott J, Spitzer RL, Fleiss JL, Cohen J: The Global Assessment Scale: a procedure for measuring overall severity of psychiatric disturbance. Arch Gen Psychiatry 1976; 33:766–771
Kay SR, Fiszbein A, Opler LA: The Positive and Negative Syndrome Scale (PANSS) for schizophrenia. Schizophr Bull 1987; 13:261–276
Nuechterlein GK, Subotnik KL, Ventura J, Mintz J, Fogelson DL, Bartzokis G, Aravagiri M: Clinical outcome following neuroleptic discontinuation in patients with remitted recent-onset schizophrenia. Am J Psychiatry 2001; 158:1835–1842
Verdoux H, Lengronne J, Liraud F, Gonzales B, Assens F, Abalan F, van Os J: Medication adherence in psychosis: predictors and impact on outcome: a 2-year follow-up of first-admitted subjects. Acta Psychiatr Scand 2000; 102:203–210
Coldham EL, Addington J, Addington D: Medication adherence of individuals with a first episode of psychosis. Acta Psychiatr Scand 2002; 106:286–290
Larsen TK, Johannessen JO, Opjordsmoen S: First-episode schizophrenia with long duration of untreated psychosis: pathways to care. Br J Psychiatry Suppl 1998; 172:45–52
Loebel AD, Lieberman JA, Alvir JM, Mayerhoff DI, Geisler SH, Szymanski SR: Duration of psychosis and outcome in first-episode schizophrenia. Am J Psychiatry 1992; 149:1183–1188
Haas GL, Garratt LS, Sweeney JA: Delay to first antipsychotic medication in schizophrenia: impact on symptomatology and clinical course of illness. J Psychiatr Res 1998; 32:151–159
Larsen JK, Johannessen JO, Guldberg CA, Opjordsmoen S, Vaglum P, McGlashan TH: Early intervention programs in first-episode psychosis and reduction of duration of untreated psychosis. Schizophr Res 2000; 36:344–345
Robinson DG, Woerner MG, Alvir JMJ, Geisler S, Koreen A, Sheitman B, Chakos M, Mayerhoff D, Bilder R, Goldman R, Lieberman JA: Predictors of treatment response from a first episode of schizophrenia or schizoaffective disorder. Am J Psychiatry 1999; 156:544–549
Harrison G, Croudace T, Mason P, Glazebrook C, Medley I: Predicting the long-term outcome of schizophrenia. Psychol Med 1996; 26:697–705
Moller P: Duration of untreated psychosis: are we ignoring the mode of initial development? an extensive naturalistic case study of phenomenal continuity in first-episode schizophrenia. Psychopathology 2001; 34:8–14
Madsen AL, Vorstrup S, Rubin P, Larsen JK, Hemmingsen R: Neurological abnormalities in schizophrenic patients: a prospective follow-up study 5 years after first admission. Acta Psychiatr Scand 1999; 100:119–125
Weinberger DR, McClure RK: Neurotoxicity, neuroplasticity, and magnetic resonance imaging morphometry: what is happening in the schizophrenic brain? Arch Gen Psychiatry 2002; 59:553–558
Robinson DG, Woerner MG, Alvir JM, Bilder RM, Hinrichsen GA, Lieberman JA: Predictors of medication discontinuation by patients with first-episode schizophrenia and schizoaffective disorder. Schizophr Res 2002; 57:209–219
Ran MS, Xiang MZ, Li SX, Shan YH, Huang MS, Li SG, Liu ZR, Chen EY, Chan CL: Prevalence and course of schizophrenia in a Chinese rural area. Aust NZ J Psychiatry 2003; 37:452–457
Cahn W, Pol HE, Lems EB, van Haren NE, Schnack HG, van der Linden JA, Schothorst PF, van Engeland H, Kahn RS: Brain volume changes in first-episode schizophrenia: a 1-year follow-up study. Arch Gen Psychiatry 2002; 59:1002–1010
Lieberman J, Chakos M, Wu H, Alvir J, Hoffman E, Robinson D, Bilder R: Longitudinal study of brain morphology in first episode schizophrenia. Biol Psychiatry 2001; 49:487–499
Ho B-C, Andreasen NC, Nopoulos P, Arndt S, Magnotta V, Flaum M: Progressive structural brain abnormalities and their relationship to clinical outcome: a longitudinal magnetic resonance imaging study early in schizophrenia. Arch Gen Psychiatry 2003; 60:585–594
Lieberman JA, Fenton WS: Delayed detection of psychosis: causes, consequences, and effect on public health. Am J Psychiatry 2000; 157:1727–1730
Lincoln C, Harrigan S, McGorry PD: Understanding the topography of the early psychosis pathways: an opportunity to reduce delays in treatment. Br J Psychiatry Suppl 1998; 172:21–25
Addington J, van Mastrigt S, Hutchinson J, Addington D: Pathways to care: help seeking behaviour in first episode psychosis. Acta Psychiatr Scand 2002; 106:358–364
Marquis S, Moore MM, Howieson DB, Sexton G, Payami H, Kaye JA, Camicioli R: Independent predictors of cognitive decline in healthy elderly persons. Arch Neurol 2002; 59:601–606
Pantelis C, Velakoulis D, McGorry PD, Wood SJ, Suckling J, Phillips LJ, Yung AR, Bullmore ET, Brewer W, Soulsby B, Desmond P, McGuire PK: Neuroanatomical abnormalities before and after onset of psychosis: a cross-sectional and longitudinal MRI comparison. Lancet 2003; 361:281–288
Robinson DG, Woerner MG, McMeniman M, Mendelowitz A, Bilder RM: Symptomatic and functional recovery from a first episode of schizophrenia or schizoaffective disorder. Am J Psychiatry 2004; 161:473–479
Lieberman JA: Is schizophrenia a neurodegenerative disorder? a clinical and neurobiological perspective. Biol Psychiatry 1999; 46:729–739
Margolis RL, Chuang DM, Post RM: Programmed cell death: implications for neuropsychiatric disorders. Biol Psychiatry 1994; 35:946–956
Fuller R, Nopoulos P, Arndt S, O’Leary D, Ho B-C, Andreasen NC: Longitudinal assessment of premorbid cognitive functioning in patients with schizophrenia through examination of standardized scholastic test performance. Am J Psychiatry 2002; 159:1183–1189
Ang YG, Tan HY: Academic deterioration prior to first episode schizophrenia in young Singaporean males. Psychiatry Res 2004; 121:303–307